Better care for cancer patients may be on the horizon. A new prescription medicine for treating cervical cancer has been showing positive results in clinical trials. In phase 3 global trials, TIVDAK (tisotumab vedotin) was linked to a 30% overall reduction in the risk of death compared to chemotherapy. BREAST …
Read More »Cervical cancer drug raises survival rate by 30% compared to chemotherapy: 'Game-changer'
